PE Tech Report


Like this article?

Sign up to our free newsletter

Cytomos secures £1.6m additional seed funding led by Archangels

Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £1.6m funding to progress the development and qualification of its novel cell analysis platform, Cytomos Dielectric Spectroscopy (CDS).

The fundraising round by Cytomos was led by existing investor Archangels with participation from Scottish Enterprise and Old College Capital.
Cytomos has developed its technology platform to address the unmet needs of the biopharma industry, providing a low-cost, portable and scalable alternative.  

Founded in 1992, Archangels is the world’s oldest continuously operating business angel syndicate investing in early-stage Scottish life sciences and technology companies. The syndicate was an early investor in Cytomos and has supported the team through early-stage development of the business.

Like this article? Sign up to our free newsletter